You are here: Home pathway Area of law pathway Reminyl

Defective Drugs Lawyers and Attorneys Legal Help

Reminyl

REMINYL is used to treat dementia in Alzheimer's disease and is manufactured by Ortho-McNeil. The symptoms of Alzheimer's disease include confusion, memory loss or other changes in behavior. As the disease progresses, patients find it more and more difficult to carry out their normal daily activities.

The indications of Alzheimer's disease are considered to be due to a lack of acetylcholine, a substance that transmits messages between brain cells. REMINYL increases the amount of this substance to help improve or stabilize the symptoms and therefore slow the progress of Alzheimer's disease.

Your doctor may have prescribed REMINYL for another reason. Ask you doctor if you have any questions about why this medicine has been prescribed for you.

Ortho-McNeil Neurologics amended the PRECAUTIONS section of the Prescribing Information for Reminyl, approved only for the treatment of mild to moderate Alzheimer's Disease. The changes provide new safety information regarding the results of two randomized, placebo-controlled trials of 2 years duration in subjects with mild cognitive impairment (MCI). A total of 13 subjects on REMINYL (n=1026) and 1 subject on placebo (n=1022) died. The fatalities were due to a variety of causes, which could be expected, in an elderly population. About half of the REMINYL deaths appeared to result from various vascular causes (myocardial infarction, stroke), and sudden death.